Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Multiple unit HLA-unmatched sex-mismatched umbilical cord blood transplantation for advanced hematological malignancy.

Lister J, Gryn JF, McQueen KL, Harris DT, Rossetti JM, Shadduck RK.

Stem Cells Dev. 2007 Feb;16(1):177-86.

PMID:
17348813
2.

Treatment of acute myelogenous leukemia with outpatient azacitidine.

Sudan N, Rossetti JM, Shadduck RK, Latsko J, Lech JA, Kaplan RB, Kennedy M, Gryn JF, Faroun Y, Lister J.

Cancer. 2006 Oct 15;107(8):1839-43.

3.

Factors affecting purification of CD34(+) peripheral blood stem cells using the Baxter Isolex 300i.

Gryn J, Shadduck RK, Lister J, Zeigler ZR, Raymond JM.

J Hematother Stem Cell Res. 2002 Aug;11(4):719-30.

PMID:
12201961
4.

Treatment of myelodysplastic syndromes with 5-azacytidine.

Gryn J, Zeigler ZR, Shadduck RK, Lister J, Raymond JM, Sbeitan I, Srodes C, Meisner D, Evans C.

Leuk Res. 2002 Oct;26(10):893-7.

PMID:
12163049
5.

Clearance of erythrocyte allo-antibodies using Rituximab.

Gryn J, Zeigler ZR, Shadduck RK, Thomas C.

Bone Marrow Transplant. 2002 Apr;29(7):631-2. No abstract available.

6.

Cryoprecipitate poor plasma does not improve early response in primary adult thrombotic thrombocytopenic purpura (TTP).

Zeigler ZR, Shadduck RK, Gryn JF, Rintels PB, George JN, Besa EC, Bodensteiner D, Silver B, Kramer RE; North American TTP Group.

J Clin Apher. 2001;16(1):19-22.

PMID:
11309826
7.

Plasminogen activator inhibitor (PAI-1) antigen levels in primary TTP and secondary TTP post-bone marrow transplantation.

Anthony MT, Zeigler ZR, Lister J, Raymond JM, Shadduck RK, Kramer RE, Gryn JF, Rintels PB, Besa EC, George JN, Silver B, Joyce R, Bodensteiner D.

Am J Hematol. 1998 Sep;59(1):9-14.

8.

Targeted gene conversion in a mammalian CD34+-enriched cell population using a chimeric RNA/DNA oligonucleotide.

Xiang Y, Cole-Strauss A, Yoon K, Gryn J, Kmiec EB.

J Mol Med (Berl). 1997 Nov-Dec;75(11-12):829-35.

PMID:
9428613
9.

The treatment of relapsed or refractory intermediate grade non-Hodgkin's lymphoma with autologous bone marrow transplantation followed by cyclosporine and interferon.

Gryn J, Johnson E, Goldman N, Devereux L, Grana G, Hageboutros A, Fernandez E, Constantinou C, Harrer W, Viner E, Goldberg J.

Bone Marrow Transplant. 1997 Feb;19(3):221-6.

10.

Plasma von Willebrand Factor Antigen (vWF:AG) and thrombomodulin (TM) levels in Adult Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndromes (TTP/HUS) and bone marrow transplant-associated thrombotic microangiopathy (BMT-TM).

Zeigler ZR, Rosenfeld CS, Andrews DF 3rd, Nemunaitis J, Raymond JM, Shadduck RK, Kramer RE, Gryn JF, Rintels PB, Besa EC, George JN.

Am J Hematol. 1996 Dec;53(4):213-20.

11.

Correction of the mutation responsible for sickle cell anemia by an RNA-DNA oligonucleotide.

Cole-Strauss A, Yoon K, Xiang Y, Byrne BC, Rice MC, Gryn J, Holloman WK, Kmiec EB.

Science. 1996 Sep 6;273(5280):1386-9.

PMID:
8703073
12.

Detection and monitoring of a concomitant atypical myeloproliferative disorder and chronic lymphocytic leukemia by flow-cytometric immunophenotyping.

McCoy JP Jr, Johnson E, Catalano E, Blumstein L, Overton WR, Gryn J, Donaldson MH.

Arch Pathol Lab Med. 1995 Nov;119(11):1038-43.

PMID:
7487404
13.

The physiologic effects of inhaled amphotericin B.

Dubois J, Bartter T, Gryn J, Pratter MR.

Chest. 1995 Sep;108(3):750-3.

PMID:
7656628
14.

Pentostatin increases the acute toxicity of high dose cyclophosphamide.

Gryn J, Gordon R, Bapat A, Goldman N, Goldberg J.

Bone Marrow Transplant. 1993 Sep;12(3):217-20.

PMID:
8241979
15.

Mitoxantrone and 5-azacytidine for refractory/relapsed ANLL or CML in blast crisis: a leukemia intergroup study.

Goldberg J, Gryn J, Raza A, Bennett J, Browman G, Bryant J, Grunwald H, Larson R, Vogler R, Preisler H.

Am J Hematol. 1993 Aug;43(4):286-90.

PMID:
7690519
16.

The toxicity of daily inhaled amphotericin B.

Gryn J, Goldberg J, Johnson E, Siegel J, Inzerillo J.

Am J Clin Oncol. 1993 Feb;16(1):43-6.

PMID:
8424403
17.

Emergencies of indwelling venous catheters.

Gryn J, Sacchetti A.

Am J Emerg Med. 1992 May;10(3):254-7. Review. No abstract available.

PMID:
1586439
18.

Propranolol for the treatment of cyclosporine-induced headaches.

Gryn J, Goldberg J, Viner E.

Bone Marrow Transplant. 1992 Mar;9(3):211-2.

PMID:
1511258
19.

High-dose cytosine arabinoside and etoposide in the treatment of relapsed or refractory adult leukemia.

Gryn J, Conroy J, Topolsky D, Crilley P, Kahn SB, Bulova S, Weiss J, Brodsky I.

Am J Clin Oncol. 1991 Feb;14(1):52-4.

PMID:
1987740
20.

Tretinoin for the treatment of cutaneous graft-versus-host disease.

Gryn J, Crilley P.

Bone Marrow Transplant. 1990 Apr;5(4):279-80.

PMID:
2104506

Supplemental Content

Support Center